Insider plans sale of 7,315 shares of common stock under Form 144

An insider of the issuer has filed a Form 144 notice to sell 7,315 shares of common stock through broker Morgan Stanley Smith Barney LLC on the NYSE.

Rhea-AI Filing Summary

An insider of the issuer has filed a Form 144 notice to sell 7,315 shares of common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $331,390.71, while 47,374,939 shares of this class were outstanding at the time of the notice. The shares to be sold were acquired as restricted stock from the issuer on 02/22/2019 and 02/21/2020.

Over the past three months, the same seller, Jean F. Holloway, has already sold several blocks of common stock, including 10,000 shares on 11/11/2025 for gross proceeds of $461,800.00. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing related to AORT disclose?

The filing discloses that an insider intends to sell 7,315 shares of common stock on the NYSE, with an aggregate market value of $331,390.71, and that these shares were acquired as restricted stock from the issuer in 2019 and 2020.

Who is selling shares in this AORT-related Form 144 and through which broker?

The seller is Jean F. Holloway, who plans to sell the shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many shares of the issuer’s common stock are outstanding according to the Form 144?

The notice states that there are 47,374,939 shares of the issuer’s common stock outstanding.

What prior stock sales by Jean F. Holloway are reported in the past three months?

The notice lists several prior sales of common stock by Jean F. Holloway, including 10,000 shares on 11/11/2025 for gross proceeds of $461,800.00, plus other sales on 11/10/2025, 11/13/2025, 11/14/2025, and 11/17/2025.

How were the shares being sold in this AORT Form 144 originally acquired?

The shares were acquired as restricted stock from the issuer on 02/22/2019 (2,048 securities) and 02/21/2020 (5,267 securities), with payment noted as Not Applicable in the form.

What representation does the seller make about inside information in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/03/2025 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001540065
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARTIVION, INC.
SEC File Number	001-13165
Address of Issuer	1655 ROBERTS BLVD NW KENNESAW GEORGIA 30144
Phone	(770) 419-3355
Name of Person for Whose Account the Securities are To Be Sold	JEAN F HOLLOWAY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7315	331390.71	47374939	12/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/22/2019	Restricted Stock	Issuer			2048	02/22/2019	Not Applicable
Common	02/21/2020	Restricted Stock	Issuer			5267	02/21/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	11/17/2025	6394	288816.98
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	11/14/2025	6393	287685.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	11/13/2025	5761	264187.94
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	11/11/2025	10000	461800.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	COMMON	11/10/2025	2960	132072.24

144: Remarks and Signature

Remarks
Date of Notice	12/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jean Frames Holloway
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)